While it still unclear what mystery bill(s) the Senate will actually vote on, all of the options under consideration would have devastating consequences for millions of people with health insurance coverage.
Archives: Press Releases : Page 2
Health care coverage through the Affordable Care Act (ACA), Medicare and Medicaid is under assault. The Congressional Budget Office finally released its estimate regarding the devastating impact of the AHCA bill that passed the House earlier this month. Now a select group of Senators is considering its own version of AHCA, also seeking to repeal the Affordable Care Act. Meanwhile, the Trump Administration released a proposed budget that would all but destroy Medicaid.
More than 75 national organizations sent a letter to Senate leadership today, urging them to reject the American Health Care Act (AHCA).
By four votes, the House of Representatives passed the American Health Care Act (AHCA) today, a bill that guts the Affordable Care Act (ACA), decimates Medicaid, and undermines Medicare. This is not a health care bill.
On March 20, a bad bill - the AHCA - got worse. It would lead to 24 million people losing coverage, increase costs for individuals and yield $187 billion LESS in savings.
Instead of providing meaningful improvement to ACA, this proposed bill represents a regression to the less secure, pre-ACA health insurance environment.
Recent proposals put forward in Congress would completely restructure Medicaid’s finances, eligibility, and availability, leading to fewer people covered, fewer services available, and higher health care costs for low-income families.
On February 16, 2017, the Jimmo v. Sebelius court approved a Corrective Statement to be used by the Centers for Medicare and Medicaid Services (CMS) to affirmatively disavow the use of an “Improvement Standard” for Medicare coverage.
In light of Sec. Price’s previous statements threatening Medicare, Medicaid, and the Affordable Care Act, the Center for Medicare Advocacy will be vigilant during his tenure.
Any legislation to repeal the ACA should be rejected unless it is accompanied by a detailed replacement plan that provides American families with equal or improved access to high-quality, affordable health coverage.
The Department of Justice's $2.2 billion settlement with Johnson & Johnson over allegations that it illegally promoted Risperdal to treat symptoms of dementia sends a new warning to the pharmaceutical and long-term care industries that antipsychotic drugs are inappropriate and potentially dangerous when prescribed for the elderly.